Literature DB >> 17053912

Cytokine-adjuvanted HIV-DNA vaccination strategies.

Franco Lori1, David B Weiner, Sandra A Calarota, Laurene M Kelly, Julianna Lisziewicz.   

Abstract

This review highlights some of the most common cytokines currently being tested as adjuvants in HIV-1-DNA vaccine regimens. We discuss their use in both the prophylactic and therapeutic setting. Finally, we describe a novel dendritic cell-targeted vaccine candidate for HIV-1 treatment and prevention called DermaVir and explore the combination of the DermaVir technology with the cytokine adjuvants interleukin-7 and interleukin-15.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17053912     DOI： 10.1007/s00281-006-0047-y

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


  82 in total

1.  IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses.

Authors:  T Hiroi; M Yanagita; N Ohta; G Sakaue; H Kiyono
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 2.  Viral evolution and challenges in the development of HIV vaccines.

Authors:  Dan H Barouch; Norman L Letvin
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

3.  IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.

Authors:  K Song; Y Chang; G J Prud'homme
Journal:  Gene Ther       Date:  2000-09       Impact factor: 5.250

Review 4.  Interleukin-12: a cytokine at the interface of inflammation and immunity.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

5.  Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens.

Authors:  J J Kim; N N Trivedi; L K Nottingham; L Morrison; A Tsai; Y Hu; S Mahalingam; K Dang; L Ahn; N K Doyle; D M Wilson; M A Chattergoon; A A Chalian; J D Boyer; M G Agadjanyan; D B Weiner
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

6.  DermaVir: a novel topical vaccine for HIV/AIDS.

Authors:  Julianna Lisziewicz; Jeffrey Trocio; Lucia Whitman; Georg Varga; Jianqing Xu; Nyasha Bakare; Patrick Erbacher; Cecil Fox; Ruth Woodward; Phil Markham; Suresh Arya; Jean-Paul Behr; Franco Lori
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

7.  Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent.

Authors:  S E Macatonia; C S Hsieh; K M Murphy; A O'Garra
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

8.  Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.

Authors:  D H Barouch; A Craiu; M J Kuroda; J E Schmitz; X X Zheng; S Santra; J D Frost; G R Krivulka; M A Lifton; C L Crabbs; G Heidecker; H C Perry; M E Davies; H Xie; C E Nickerson; T D Steenbeke; C I Lord; D C Montefiori; T B Strom; J W Shiver; M G Lewis; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

9.  In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.

Authors:  J I Sin; J J Kim; J D Boyer; R B Ciccarelli; T J Higgins; D B Weiner
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid.

Authors:  S S Frankel; B M Wenig; A P Burke; P Mannan; L D Thompson; S L Abbondanzo; A M Nelson; M Pope; R M Steinman
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728
View more
  12 in total

Review 1.  Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

Authors:  Shaw-Wei D Tsen; Augustine H Paik; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

2.  Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit.

Authors:  Antonio Valentin; Agneta von Gegerfelt; Margherita Rosati; Georgios Miteloudis; Candido Alicea; Cristina Bergamaschi; Rashmi Jalah; Vainav Patel; Amir S Khan; Ruxandra Draghia-Akli; George N Pavlakis; Barbara K Felber
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

3.  Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy.

Authors:  Jing Sun; Dingfeng Li; Yanling Hao; Yuwei Zhang; Wenling Fan; Jingjing Fu; Yunzhang Hu; Yong Liu; Yiming Shao
Journal:  DNA Cell Biol       Date:  2009-05       Impact factor: 3.311

4.  Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation.

Authors:  Margherita Rosati; Antonio Valentin; Rashmi Jalah; Vainav Patel; Agneta von Gegerfelt; Cristina Bergamaschi; Candido Alicea; Deborah Weiss; Jim Treece; Ranajit Pal; Phillip D Markham; Ernesto T A Marques; J Thomas August; Amir Khan; Ruxandra Draghia-Akli; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2008-04-21       Impact factor: 3.641

5.  Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.

Authors:  Ellen E Sparger; Robert A Dubie; Barbara L Shacklett; Kelly S Cole; W L Chang; Paul A Luciw
Journal:  Virology       Date:  2008-02-07       Impact factor: 3.616

6.  Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251.

Authors:  Robert A Dubie; Saipiroon Maksaereekul; Barbara L Shacklett; Donna Lemongello; Kelly S Cole; Francois Villinger; Shelley A Blozis; Paul A Luciw; Ellen E Sparger
Journal:  Virology       Date:  2009-02-03       Impact factor: 3.616

7.  The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice.

Authors:  Ye Liu; Fusheng Li; Zhi Qi; Yanling Hao; Kunxue Hong; Yong Liu; Yulong Cong; Yiming Shao
Journal:  Virol J       Date:  2013-09-30       Impact factor: 4.099

8.  Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.

Authors:  T H Kang; J-Y Chung; A Monie; S I Pai; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2009-11-26       Impact factor: 5.250

9.  Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.

Authors:  Gözde Isik; Kwinten Sliepen; Thijs van Montfort; Rogier W Sanders
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

Review 10.  Vaccines for the 21st century.

Authors:  Isabel Delany; Rino Rappuoli; Ennio De Gregorio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.